Name | Type | Posted | Actions |
|---|---|---|---|
Att 22_Schedule of Contract Prices.xlsx | XLSX | Sep 14, 2022 | |
Att 1_Packaging and Delivery of Proposals for Use with the NIH eCPS website.docx | DOCX | Sep 14, 2022 | |
Att 2_intent.pdf | Sep 14, 2022 | ||
Att 3 - SOW final.pdf | Sep 14, 2022 | ||
Att 4 - Property.pdf | Sep 14, 2022 | ||
Att 5_Section K.pdf | Sep 14, 2022 | ||
Att 13_Wage Determination.pdf | Sep 14, 2022 | ||
Att 15_Invoicing Instructions Without IPP Updated 8-15-22.docx | DOCX | Sep 14, 2022 | |
Att 15_NIH(RC)2 Final.pdf | Sep 14, 2022 | ||
Att 21_Sample TO with Year 1 Contract Prices.pdf | Sep 14, 2022 | ||
RFP_75N95022R00097.pdf | Sep 14, 2022 |
NIDA Center for Genetic Studies
Contact and place of performance
—
Not specified
No narrative description provided for this notice.
The National Institute on Drug Abuse (NIDA) is seeking proposals for the NIDA Center for Genetic Studies under solicitation number 75N95022R00097. This federal opportunity is classified under NAICS code 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC code AN11 for Health R&D Services; Health Care; Basic Research. The notice was published on August 15, 2022, and received its last update on October 14, 2022.
The solicitation documentation includes 11 attachments, featuring a statement of work, property requirements, a schedule of contract prices, and instructions for the packaging and delivery of proposals via the NIH eCPS website. Other included files provide guidance on letters of intent and Section K certifications. Specific performance locations and response deadlines are not detailed in the primary notice metadata.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.